JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

146.74

-0.99%↓

Kodu・Aktsiate loetelu・Rockwell Medical Inc

Rockwell Medical Inc

Suletud

SektorTervishoid

1.13 -3.42

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.13

Max

1.17

Põhinäitajad
By Trading Economics
Aktsiakasum	-0.04
Töötajad	244

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+244.83% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	12. nov 2025

Turustatistika
By TradingEconomics
Turukapital	7.8M 35M
Eelmine avamishind	4.55
Eelmine sulgemishind	1.13

Uudiste sentiment

By Acuity

10%

90%

9 / 373 Pingereas Healthcare

Rockwell Medical Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

27. okt 2025, 23:32 UTC

Omandamised, ülevõtmised, äriostud

CSL Delays Flu-Vaccine Spinoff, Cuts Guidance As U.S. Vaccination Rates Decline

27. okt 2025, 23:00 UTC

Omandamised, ülevõtmised, äriostud

Australia's AUB Opens Books to EQT After Receiving $3.44 Billion Takeover Offer

27. okt 2025, 21:42 UTC

Tulu

Waste Management 3Q Revenue Climbs, Sees Fiscal Year Revenue at Low End of Prior View

27. okt 2025, 23:43 UTC

Market Talk

Nikkei May Rise on Easing U.S.-China Trade Tensions -- Market Talk

27. okt 2025, 23:42 UTC

Market Talk

Gold Rises on Likely Technical Recovery -- Market Talk

27. okt 2025, 23:37 UTC

Market Talk

Investors May Cheer CSL's Decision to Delay Seqirus Spinoff -- Market Talk

27. okt 2025, 23:00 UTC

Tulu

The Good Vibes Are Back on Wall Street -- WSJ

27. okt 2025, 22:45 UTC

Omandamised, ülevõtmised, äriostud

Australia's AUB Opens Books to EQT After Receiving $3.44B Takeover Offer

27. okt 2025, 22:06 UTC

Market Talk

Tulu

Nucor Expects Weaker Steel Market in 4Q -- Market Talk

27. okt 2025, 22:05 UTC

Tulu

China Southern Airlines: Continued Improvements in Business Environment Supported Results >1055.HK

27. okt 2025, 22:04 UTC

Tulu

Cadence Reports Solid Earnings. The Stock Is Falling. -- Barrons.com

27. okt 2025, 22:04 UTC

Tulu

China Southern Airlines 3Q Net CNY3.84B, Up 20.3% on Year >1055.HK

27. okt 2025, 22:03 UTC

Tulu

China Southern Airlines 3Q Rev CNY51.37B, Up 3.0% on Year >1055.HK

27. okt 2025, 21:27 UTC

Tulu

Waste Management 3Q Rev Climbs, Sees FY Rev at Low End of Prior View

27. okt 2025, 21:19 UTC

Tulu

Cadence Reports Solid Earnings. The Stock Is Falling. -- Barrons.com

27. okt 2025, 20:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Health Care Roundup: Market Talk

27. okt 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

27. okt 2025, 20:37 UTC

Tulu

Waste Management: Decrease From Prior Rev Expectations Is Primarily Related to Further Decline in Recycled Commodity Pricing, Modestly Lower Rev Expectations From Healthcare Solutions >WM

27. okt 2025, 20:37 UTC

Tulu

Waste Management: 2025 Free Cash Flow Guidance Remains Between $2.8B and $2.9B >WM

27. okt 2025, 20:37 UTC

Tulu

Waste Management: 2025 Total Co Rev Is Now Expected Approximately $25.275B >WM

27. okt 2025, 20:37 UTC

Tulu

Waste Management: Affirming 2025 Adjusted Operating EBITDA Guidance Between $7.475B and $7.625B >WM

27. okt 2025, 20:31 UTC

Tulu

Nucor Sees 4Q Earnings Lower Than 3Q

27. okt 2025, 20:30 UTC

Tulu

Nucor 3Q Steel Mills Total Shipments 6.43M Tons >NUE

27. okt 2025, 20:30 UTC

Tulu

Nucor 3Q EPS $2.63 >NUE

27. okt 2025, 20:30 UTC

Tulu

Nucor 3Q Net $607M >NUE

27. okt 2025, 20:30 UTC

Tulu

Nucor 3Q Sales $8.52B >NUE

27. okt 2025, 20:30 UTC

Tulu

Nucor 3Q Total Tons Shipped to Outside Customers Down 1% >NUE

27. okt 2025, 20:30 UTC

Tulu

Waste Management 3Q Adj EPS $1.98 >WM

27. okt 2025, 20:30 UTC

Tulu

Waste Management 3Q Rev $6.44B >WM

27. okt 2025, 20:30 UTC

Tulu

Waste Management 3Q Net $603M >WM

Võrdlus sarnastega

Hinnamuutus

Rockwell Medical Inc Prognoos

Hinnasiht

By TipRanks

244.83% tõus

12 kuu keskmine prognoos

Keskmine 4 USD 244.83%

Kõrge 5 USD

Madal 3 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Rockwell Medical Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Rockwell Medical Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

9 / 373 Pingereas Tervishoid

Finantsandmed

Ettevõttest Rockwell Medical Inc

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.